Basak, M., Sharif, O., Lord, S. E., Borodovsky, J. T., Marsch, L. A., Springer, S. A., Nunes, E. V., Brackett, C. D., Archibald, L. J., & Preum, S. M. (2025). Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit Data. Journal of Medical Internet Research, 27, e68886. https://doi.org/10.2196/68886

Seval, N., Roth, P., Frank, C. A., Di Paola, A., Litwin, A. H., Vander Wyk, B., Neirinckx, V., Schlossberg, E., Lawson, P., Strong, M., Schade, M. A., Nunez, J., Levin, F. R., Brady, K. T., Nunes, E. V., & Springer, S. A. (2025). Initiating Injectable Buprenorphine in People Hospitalized With Infections. JAMA Network Open, 8(5), e2513000. https://doi.org/10.1001/jamanetworkopen.2025.13000

Balise, R. R., Hu, M.-C., Calderon, A. R., Odom, G. J., Brandt, L., Luo, S. X., & Feaster, D. J. (2024). Data cleaning and harmonization of clinical trial data: Medication-assisted treatment for opioid use disorder. PLOS ONE, 19(11), e0312695. https://doi.org/10.1371/journal.pone.0312695

Presskreischer, R., Mojtabai, R., Mauro, C., Zhang, Z., Wall, M., & Olfson, M. (2025). Medicaid expansion and medications to treat opioid use disorder in outpatient specialty care from 2010 to 2020. Journal of Substance Use and Addiction Treatment, 168, 209568. https://doi.org/10.1016/j.josat.2024.209568

Ross, R. K., Inose, S., Shulman, M., Nunes, E. V., Zalla, L. C., Burlew, A. K., & Rudolph, K. E. (2024). Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity. JAMA Network Open, 7(10), e2436612. https://doi.org/10.1001/jamanetworkopen.2024.36612

Williams, A. R., Mauro, C. M., Chiodo, L., Huber, B., Cruz, A., Crystal, S., Samples, H., Nowels, M., Wilson, A., Friedmann, P. D., Remien, R. H., & Olfson, M. (2024). Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care. Drug and Alcohol Dependence, 263, 112389. https://doi.org/10.1016/j.drugalcdep.2024.112389

Williams, A. R., Mauro, C. M., Huber, B., Chiodo, L., Crystal, S., Samples, H., & Olfson, M. (2024). Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement. American Journal of Psychiatry, 181(5), 457–459. https://doi.org/10.1176/appi.ajp.20230808